Domain (Residue #) | Peptide Sequence | Observed (m/z) | Monoiostopioc M r Calculated Observed | Ratio | |
---|---|---|---|---|---|
RING I | 246SPVLVFQC(SO2H)NSR256 | 640.912+ | 1280.62 | 1279.81 | n/a |
(238 - 293) | 246SPVLVFQC(SO3H)NSR256 | 649.422+ | 1296.61 | 1296.83 | n/a |
IBR | 349KVTCEGGNGLGC(SO3H)GFAFCR366 | 623.313+ | 1865.79 | 1866.91 | 3.53 |
(294 - 417) | 350VTC(SO2H)EGGNGLGC(SO3H)GFAFCREC(SO2H)K369 | 721.513+ | 2161.82 | 2161.50 | n/a |
RING II | 421C(SO3H)HVPVEK427 | 421.932+ | 842.40 | 841.84 | 13.15 |
(418 - 449) | 428NGGC(SO2H)MHM(Oxidation)KCPQPQC(CAM)R442 | 897.892+ | 1793.69 | 1793.77 | n/a |
Others | 90NAAGGC(SO3H)EREPQSLTR104 | 819.022+ | 1635.73 | 1636.03 | 5.20 |
(1 - 237) | 212C(SO3H)GAHPTSDKETPVALHLIATNSR234 | 822.403+ | 2465.20 | 2464.17 | 1.65 |